Celldex Therapeutics and FMT Plan for Prevention
Celldex Therapeutics, headquartered in Hampton, New Jersey, is in the business of prevention. Researchers at Celldex, like their predecessor Jonas Salk, believe in
the power of the body’s immune system to combat any kind of disease. If successful, Celldex will be one of the first companies to commercialize immuno-oncology products targeted to breast cancer and other oncology indications, which, worldwide, account for nearly two million new cases diagnosed in 2012 alone.